Skip to main navigation Skip to search Skip to main content

What is the value of a food and drug administration investigational new drug application for fecal microbiota transplantation to treat clostridium difficile infection?

  • Gail A. Hecht
  • , Martin J. Blaser
  • , Jeffrey Gordon
  • , Lee M. Kaplan
  • , Rob Knight
  • , Loren Laine
  • , Richard Peek
  • , Mary Ellen Sanders
  • , Balfour Sartor
  • , Gary D. Wu
  • , Vincent W. Yang
  • Loyola University Chicago
  • New York University
  • Washington University St. Louis
  • Massachusetts General Hospital
  • University of Colorado Boulder
  • Yale University
  • Department of Veterans Affairs
  • Vanderbilt University
  • International Scientific Association for Probiotics and Prebiotics
  • University of North Carolina at Chapel Hill
  • University of Pennsylvania

Research output: Contribution to journalEditorial

20 Scopus citations
Original languageEnglish
Pages (from-to)289-291
Number of pages3
JournalClinical Gastroenterology and Hepatology
Volume12
Issue number2
DOIs
StatePublished - Feb 2014

Fingerprint

Dive into the research topics of 'What is the value of a food and drug administration investigational new drug application for fecal microbiota transplantation to treat clostridium difficile infection?'. Together they form a unique fingerprint.

Cite this